LeonaBio (LONA) Free Cash Flow (2019 - 2026)
LeonaBio (LONA) reported Free Cash Flow of -$20.9 million for Q1 2026, down 42.54% year-over-year from -$36.4 million in Q1 2025, and down 7.76% quarter-over-quarter from -$19.4 million in Q4 2025.
LeonaBio (LONA) Free Cash Flow (2019 - 2026) Analysis & Trends
LeonaBio (LONA) has 8 years of Free Cash Flow data on file, last reported at -$20.9 million in Q1 2026.
- Free Cash Flow for Q1 2026 came in at -$20.9 million, down 42.54% year-over-year; the trailing twelve-month figure through Mar 2026 was -$52.0 million (up 39.61% YoY), and the FY2025 annual result was -$45.7 million, up 52.96% from the prior year.
- Free Cash Flow declined to -$20.9 million in Q1 2026 per LONA's latest filing, from -$19.4 million in the prior quarter.
- Over five years, Free Cash Flow peaked at -$4.7 million in Q3 2025 and troughed at -$26.4 million in Q1 2023.
- A 5-year average of -$19.9 million and a median of -$21.9 million in 2022 frame the typical range for Free Cash Flow.
- The sharpest annual moves came in 2022 and 2025: Free Cash Flow slumped 152.2% in 2022, then soared 79.72% in 2025.
- A 5-year view of Free Cash Flow shows it stood at -$15.7 million in 2022, then plunged by 67.81% to -$26.3 million in 2023, then increased by 1.06% to -$26.0 million in 2024, then rose by 25.43% to -$19.4 million in 2025, then decreased by 7.76% to -$20.9 million in 2026.
- Business Quant data shows LONA's Free Cash Flow at -$20.9 million in Q1 2026, -$19.4 million in Q4 2025, and -$4.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -1.67 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -12.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.49 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.29 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 63,220.27 |
| 10 | LeonaBio | 154.12 Mn | 86.44 Mn | - | -20.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -20.90 Mn |
| Mar 31, 2026 | -20.90 Mn |
| Dec 31, 2025 | -19.40 Mn |
| Dec 31, 2025 | -19.40 Mn |
| Sep 30, 2025 | -4.67 Mn |
| Sep 30, 2025 | -4.67 Mn |
| Jun 30, 2025 | -7.00 Mn |
| Jun 30, 2025 | -7.00 Mn |
| Mar 31, 2025 | -14.67 Mn |
| Mar 31, 2025 | -14.67 Mn |
| Dec 31, 2024 | -26.01 Mn |
| Dec 31, 2024 | -26.01 Mn |
| Sep 30, 2024 | -23.02 Mn |
| Sep 30, 2024 | -23.02 Mn |
| Jun 30, 2024 | -22.36 Mn |
| Jun 30, 2024 | -22.36 Mn |
| Mar 31, 2024 | -25.81 Mn |
| Mar 31, 2024 | -25.81 Mn |
| Dec 31, 2023 | -26.29 Mn |
| Dec 31, 2023 | -26.29 Mn |